Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Treatment of dyslipidemia patients with lipid-lowering drugs leads to a significant reduction in low-density lipoproteins (LDL) level and a low to moderate level of increase in high-density lipoprotein (HDL) cholesterol in plasma. However, a possible role of these drugs in altering morphology and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Madasamy, Shanmugavel, Liu, David, Lundry, Jason, Alderete, Benjamin, Kong, Raymond, Robinson, J. Paul, Wu, Alan H.B., Amento, Edward P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MyJove Corporation 2017
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755343/
https://www.ncbi.nlm.nih.gov/pubmed/29155776
http://dx.doi.org/10.3791/56596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755343/
https://www.ncbi.nlm.nih.gov/pubmed/29155776
http://dx.doi.org/10.3791/56596

Ejemplares similares